NNBXF Nanobiotix S.A.
Price Chart
Executive Summary
Nanobiotix closed its global offering of 1,959,289 ordinary shares (€33.60 each), 225,373 ADSs ($38.98 each), 345,099 pre-funded warrants (€33.57 each), and 33,805 additional ADSs from the over-allotment option. The offering provides capital but adds approximately 2.56 million share equivalents, diluting existing holders by an estimated 4.5%.
Actionable Insight
With the offering closed, near-term dilution is now known. Watch for cash runway updates and clinical milestones for NBTXR3. The smaller-than-feared offering may relieve some bearish pressure, but core business risk remains.
Key Facts
- Global offering closed on May 26, 2026, as reported in Form 6-K.
- Sold 1,959,289 ordinary shares in Europe at €33.60 per share.
- Sold 225,373 ADSs in the U.S. at $38.98 per ADS.
- Sold 345,099 pre-funded warrants at €33.57 each.
- Underwriters exercised over-allotment option for 33,805 additional ADSs at $38.98 each.
- Offerings were made under shelf registration statement on Form F-3.
Financial Impact
Offering of approximately 2.56 million ordinary share equivalents, raising gross proceeds based on stated prices.
Risk Factors
- Dilution of approximately 4.5% for existing shareholders.
- Reliance on future financing for ongoing operations.
- Clinical-stage company with no approved products or material revenue.
Market Snapshot
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001140361-26-022876 |
| Document: ny20063216x4_6k.htm | 0001140361-26-022876 |
| Document: ny20063216x4_ex5-1.htm | 0001140361-26-022876 |
| Document: 0001140361-26-022876-index-headers.html | 0001140361-26-022876 |
| Document: 0001140361-26-022876-index.html | 0001140361-26-022876 |
| Document: 0001140361-26-022876.txt | 0001140361-26-022876 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 5, 2026
4d ago
|
6-K
| — | awaiting T+20 | — | — |
|
Jun 2, 2026
7d ago
|
6-K
| — | awaiting T+20 | — | — |
|
May 26, 2026
14d ago
|
6-K
| — | awaiting T+20 | — | — |
|
May 26, 2026
14d ago
|
6-K
| — | awaiting T+20 | — | — |
|
May 22, 2026
18d ago
|
6-K
| — | awaiting T+20 | — | — |
|
May 22, 2026
18d ago
|
424B5
| — | awaiting T+20 | — | — |
|
May 21, 2026
19d ago
|
6-K
| — | awaiting T+20 | — | — |
|
May 21, 2026
19d ago
|
6-K
| — | awaiting T+20 | — | — |
|
May 20, 2026
20d ago
|
6-K
| — | awaiting T+20 | — | — |
|
May 20, 2026
20d ago
|
424B5
| — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access